Darden ( DRI) estimates cut at Sterne Agee through 2015, Sterne Agee said. Industry sales trends have been weak. Buy rating and $55 price target.

Guidewire ( GWRE) numbers raised at UBS. GWRE earnings estimates were raised given momentum from sales force productivity and deal wins, said UBS. Price target is boosted to $52.

Micron ( MU) estimates increased at Lazard through 2014, Lazard Capital Markets said. Management remained positive about the DRAM market on a recent roadshow. Neutral rating.

Pfizer ( PFE) estimates, target boosted at Leerink. Shares of PFE now seen reaching $28.50, according to Leerink Swann. Estimates also upped, given higher international Lyrica sales and cost cutting. Market Perform rating.

Rowan ( RDC) estimates reduced at Jefferies to reflect a modest equipment-related delivery delay on the Renaissance ship, said Jefferies. Price target is $42.

Rosetta Resources ( ROSE) added to Best Ideas List at Wunderlich. Company is ramping production, but trades at a discount to peers.

Verizon ( VZ) estimates, target raised at Oppenheimer. Shares of VZ now seen reaching $56, according to Oppenheimer. Estimates also increased, following the wireless buyout. Outperform rating.

>To submit a news tip, email: tips@thestreet.com.

Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.

If you liked this article you might like

Nokia 8 to Launch in India First High-End NOK Phone in Years

These Stocks Have Changed Direction

Wolf Pack Descends on BroadSoft

AT&T Expanding 5G Network Trials to Test Faster Service